Department of Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China.
Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China.
Surgery. 2021 Jul;170(1):239-248. doi: 10.1016/j.surg.2021.01.042. Epub 2021 Mar 19.
Ischemia/reperfusion of the intestine often leads to distant organ injury, but the mechanism of intestinal ischemia/reperfusion-induced renal dysfunction is still not clear. The present study aimed to investigate the mechanisms of acute renal damage after intestinal ischemia/reperfusion challenge and explore the role of released high-mobility group box-1 in this process.
Intestinal ischemia/reperfusion was induced in male Sprague-Dawley rats by clamping the superior mesenteric artery for 1.5 hours. At different reperfusion time points, anti-high-mobility group box-1 neutralizing antibodies or ethyl pyruvate were administered to neutralize or inhibit circulating high-mobility group box-1, respectively.
Significant kidney injury was observed after 6 hours of intestinal reperfusion, as indicated by increased serum levels of urea nitrogen and creatinine, increased expression of neutrophil gelatinase-associated lipocalin, interleukin-6, and MIP-2, and enhanced cell apoptosis, as indicated by cleaved caspase 3 levels in renal tissues. The levels of phosphorylated eIF2ɑ, activating transcription factor 4, and C/EBP-homologous protein (CHOP) were markedly elevated, indicating the activation of endoplasmic reticulum stress in the impaired kidney. High-mobility group box-1 translocated to cytoplasm in the intestine and serum concentrations of high-mobility group box-1 increased notably during the reperfusion phase. Both anti-high-mobility group box-1 antibodies and ethyl pyruvate treatment significantly reduced serum high-mobility group box-1 concentrations, attenuated endoplasmic reticulum stress in renal tissue and inhibited the development of renal damage. Moreover, the elevated expression of receptor for advanced glycation end products in the kidneys after intestinal ischemia/reperfusion was abrogated after high-mobility group box-1 inhibition.
These results suggested that high-mobility group box-1 signaling regulated endoplasmic reticulum stress and promoted intestinal ischemia/reperfusion-induced acute kidney injury. High-mobility group box-1 neutralization/inhibition might serve as a pharmacological intervention strategy for these pathophysiological processes.
肠缺血/再灌注常常导致远处器官损伤,但肠缺血/再灌注引起肾功能障碍的机制尚不清楚。本研究旨在探讨肠缺血/再灌注后急性肾损伤的机制,并探讨释放的高迁移率族蛋白 B1 在这一过程中的作用。
通过夹闭肠系膜上动脉 1.5 小时诱导雄性 Sprague-Dawley 大鼠肠缺血/再灌注。在不同的再灌注时间点,给予抗高迁移率族蛋白 B1 中和抗体或乙基丙酮酸分别中和或抑制循环高迁移率族蛋白 B1。
肠再灌注 6 小时后观察到明显的肾脏损伤,表现为血清尿素氮和肌酐水平升高,中性粒细胞明胶酶相关脂质运载蛋白、白细胞介素-6 和 MIP-2 表达增加,以及肾组织中 cleaved caspase 3 水平升高提示细胞凋亡增强。磷酸化 eIF2ɑ、激活转录因子 4 和 C/EBP 同源蛋白(CHOP)的水平显著升高,表明受损肾脏中内质网应激的激活。高迁移率族蛋白 B1 在肠道中转位到细胞质,血清高迁移率族蛋白 B1 浓度在再灌注期明显升高。抗高迁移率族蛋白 B1 抗体和乙基丙酮酸治疗均可显著降低血清高迁移率族蛋白 B1 浓度,减轻肾组织内质网应激,抑制肾损伤的发展。此外,肠缺血/再灌注后肾脏中晚期糖基化终产物受体的表达升高,高迁移率族蛋白 B1 抑制后被阻断。
这些结果表明,高迁移率族蛋白 B1 信号调节内质网应激并促进肠缺血/再灌注引起的急性肾损伤。高迁移率族蛋白 B1 中和/抑制可能成为这些病理生理过程的药物干预策略。